Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
The transduction patterns of recombinant adeno-associated virus serotype 1 (AAV1) and serotype 6 (AAV6) vectors were assessed in human glioblastoma multiforme (GBM) cell lines, in human GBM biopsy spheroids, and in tumor xenografts growing in nude rat brains. All the cell lines tested (A172, D37, GaMg, HF66, and U373Mg) were found to be permissive to both AAV1 and AAV6 vectors, and thus displayed a transduction pattern similar to AAV2 vectors. For every cell line tested, the transduction efficiency displayed by AAV2 vectors was better than by isogenic and isopromoter AAV1 vectors. Transduction efficiency was dependent on the viral particle number used, suggesting that the receptors for these vectors are widely distributed in GBM tissues. Interestingly, AAV1, AAV2, and AAV6 vectors were able to infect and transduce the same cells when added simultaneously to monolayer cultures. Infection of human GBM biopsy spheroids with AAV1 and AAV6 vectors resulted in transgene expression both at the surface layers and in the core of the spheroids. Following injection of AAV1 and AAV6 vectors into human GBM biopsy xenografts growing in nude rat brains, reporter gene expression was seen both in the periphery as well as in the central regions of the tumors. When injected into the normal rat brain, both AAV1 and AAV6 vectors were found to transduce several central nervous system (CNS) regions. The presented results suggest a potential therapeutic role for AAV1 and AAV6 vectors in gene therapy for GBM and also for other CNS malignancies.
Huszthy
Peter C
PC
Haukeland University Hospital, N-5021 Bergen, Norway. Peter.Huszthy@helse-bergen.no
Svendsen
Agnete
A
Wilson
James M
JM
Kotin
Robert M
RM
Lønning
Per Eystein
PE
Bjerkvig
Rolf
R
Hoover
Frank
F
D000818:Animals; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D045744:Cell Line, Tumor; D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics / Q000493:pharmacokinetics*; D005909:Glioblastoma / Q000378:metabolism / Q000628:therapy*; D006651:Histocytochemistry; D006801:Humans; D007150:Immunohistochemistry; D051381:Rats; D011923:Rats, Nude; D018874:Spheroids, Cellular / Q000378:metabolism / Q000821:virology; D014161:Transduction, Genetic; D014183:Transplantation, Heterologous; D001616:beta-Galactosidase
D001616:beta-Galactosidase